Authors Posts by Head Editor

Head Editor

5007 POSTS 18 COMMENTS

0 1378

CBIS is excited, but should we be?

Cannabis Science, Inc. (OTCQB: CBIS) entered into a laboratory services agreement with ImmunoClin Corporation (IMCL) through its subsidiary, ImmunoClin Ltd., a healthcare company that has over thirteen years of experience in providing premiere laboratory and related pre-clinical and clinical research services on a commercial scale.

CBIS expects that ImmunoClin will commence cannabinoid-based drug formulation at their laboratories within the next month. Cannabis Sciences is particulary excited about starting the advanced development phase of their proprietary neurological drug, also referred to as “CS-Neuro-1″. This contract complements the CBIS’s agricultural and research programs in Spain, Italy and other European countries.

“With ImmunoClin’s track record in assisting biotech, pharma and food companies as well as public institutions in pharmaceutical and nutraceutical development projects, we are excited to initiate this long-term relationship between ImmunoClin and CBIS in the cannabinoid research field. We further benefit from the fact that ImmunoClin’s founder, Dr. Dorothy Bray, is a clinical development expert and serves at present as the Director, President and CEO of both Companies, thereby assuring smooth and effective collaboration,” stated Mr. Mario S. Lap, Director and President of European Operations, Cannabis Science, Inc.

“With the contract in place, we intend to move quickly and efficiently to assist Cannabis Science in developing proprietary formulations to bring its cannabinoid based products to patients in need,” said Khadija Benlhassan, Ph.D., Director and Chief Scientific Officer, ImmunoClin Corporation.

While this is exciting news for the company, it is only news. We are looking forward to hearing more about the developments of this project before getting constructive on the stock.

1 1684

“But Mom & Dad Why Can’t I?”

When the antidrug educator Tim Ryan talks to students, he often asks them what they know about marijuana. “It’s a plant,” is a common response.

But more recently, the answer has changed. Now they reply, “It’s legal in Colorado.”

These are confusing times for middle and high school students, who for most of their young lives have been lectured about the perils of substance abuse, particularly marijuana. Now it seems that the adults in their lives have done an about-face.

Recreational marijuana is legal in Colorado and in Washington, and many other states have approved it for medical use. Lawmakers, the news media and even parents are debating the merits of full-scale legalization.

“They are growing up in a generation where marijuana used to be bad, and maybe now it’s not bad,” said Mr. Ryan, a senior prevention specialist with FCD Educational Services, an antidrug group that works with students in the classroom.

“Their parents are telling them not to do it, but they may be supporting legalization of it at the same time.”

Antidrug advocates say efforts to legalize marijuana have created new challenges as they work to educate teenagers and their parents about the unique risks that alcohol, marijuana and other drugs pose to the developing teenage brain.

These educators say their goal is not to vilify marijuana or take a stand on legalization; instead, they say their role is to convince young people and their parents that the use of drugs is not just a moral or legal issue, but a significant health issue.

“The health risks are real,” said Steve Pasierb, the chief executive of the Partnership for Drug-Free Kids. “Every passing year, science unearths more health risks about why any form of substance use is unhealthy for young people.”

Already nearly half of teenagers — 44 percent — have tried marijuana at least once, according to data from the partnership. Regular use is less common. One in four teenagers report using marijuana in the past month, and 7 percent report frequent use — at least 20 times in the past month.

Even in the states where marijuana is legal, it remains, like alcohol, off-limits to anyone younger than 21. But the reality is that once a product becomes legal, it becomes much easier for underage users to obtain it.

This summer, the Partnership for Drug-Free Kids released its annual tracking study, in which young people were asked what stopped them from trying drugs. Getting into trouble with the law and disappointing their parents were cited as the two most common reason young people did not use marijuana. The concern now is that legalization will remove an important mental barrier that keeps adolescents from trying marijuana at a young age.

“Making it legal makes it much more accessible, more available,” said Dr. Nora Volkow, the director of the National Institute on Drug Abuse. “This is the reality, so what we need to do is to prevent the damage or at least minimize it as much as possible.”

Drug prevention experts say the “Just Say No” approach of the 1980s does not work. The goal of parents should not be to prevent their kids from ever trying marijuana.

Instead, the focus should be on practical reasons to delay use of any mind-altering substance, including alcohol, until they are older.

The reason is that young brains continue to develop until the early 20s, and young people who start using alcohol or marijuana in their teens are far more vulnerable to long-term substance-abuse problems.

The brain is still wiring itself during adolescence, and marijuana — or any drug use — during this period essentially trains the reward system to embrace a mind-altering chemical.

“We know that 90 percent of adults who are addicted began use in teenage years,” Mr. Pasierb said. “They programmed the reward and drive center of their teenage brain that this is one of those things that rewards and drives me like food does, like sex does.”

Studies in New Zealand and Canada have found that marijuana use in the teenage years can result in lost I.Q. points. Mr. Pasierb says the current generation of young people are high achievers and are interested in the scientific evidence about how substance use can affect intelligence.

“You have to focus on brain maturation,” he said. “This generation of kids wants good brains; they want to get into better schools. Talk to a junior or senior about whether marijuana use shaves a couple points off their SATs, and they will listen to you.”

Because early exposure to marijuana can change the trajectory of brain development, even a few years of delaying use in the teen years is better. Research shows that young adults who smoked pot regularly before the age of 16 performed significantly worse on cognitive function tests than those who started smoking in their later teenage years.

Drug educators say that one benefit of the legalization talk is that it may lead to more research on the health effects of marijuana on young people and more funding for antidrug campaigns.

The Partnership for Drug-Free Kids plans to continue its “Above the Influence” marketing campaign, which studies show has been an effective way of reaching teenagers about the risks of drug use. The campaign does not target a specific drug, but it teaches parents and teens about the health effects of early drug use and tries to empower teens to make good choices.

“Legalization is going to make the work we do even more relevant,” Mr. Pasierb said. “It’s part of the changing drug landscape.”

– See more at: http://marijuanastocks.com/content/legal-marijuana-parents-not-their-kids#sthash.L7zXTfv3.dpuf

0 2153

Legalize It!

So far 2014 has been a landmark year for recreational marijuana legalization. After the passage of Amendment 64 in Colorado and Initiative 502 in Washington, licensed shops opened in this year in Colorado on January 1st and Washington on July 8th. Colorado’s recreational pot business was built off of a well run and well regulated medical marijuana system. Legalization of recreational use at the beginning of this year meant many businesses merely had to change their signs and tax brackets. On the other hand, Washington’s medical marijuana was built entirely from scratch, with the state’s LCB (Liquor Control Board) placed in charge of regulation.

With these recent developments many politicians in other states are looking to see how Washington and Colorado fare with their experiment into recreational use legalization. Despite recent cuts at the federal level to DEA marijuana enforcement and prosecution, marijuana still remains a Schedule I drug and still illegal under federal law. Polarization and gridlock in the House and Senate remain strong indicators that legalization of any kind at the federal level is highly unlikely. Despite positive changes in public approval for cannabis legalization, political stagnation and inaction at the federal level means a state-by-state strategy is the only viable option for increased legalization. Looming over this state-by-state strategy is the upcoming 2016 Presidential election. If President Obama is replaced with a President who chooses to enforce marijuana as a Schedule I drug, jurisdictional and constitutional chaos will be the result.

The politics of legalization are murky and muddled at best. Without further federal level assurances, big banks will continue to not accept deposits from pot shops for fear of violating federal money-laundering laws. Investors already contending with uncertain market conditions are also weary to delve into uncertain political ones. All of these factors take away from the legitimacy and all encompassing legality that this potentially lucrative cannabis investment sector needs.

Moving forward, the price of politics may remain costly to investors who see the promise in the cannabis industry. But, as they say, “the bigger the risk, the bigger the reward.” Majorities shift and public opinion may be able to sway political compromise. Alongside this, with referendums for recreational use on the floor in three different states and potential implications for 2015 and 2016 only time will tell how the political landscape will alter the recreational one.

0 2529

Insys Therapeutics, Inc. (INSY: NASDAQ) announced that the FDA granted them orphan drug designation for their treatment of glioma. A glioma is a type of tumor that arises from the glial cells of the brain or, less commonly, the spine. Glioma accounts for approximately 30% of all brain and central nervous system tumors and 80% of all malignant brain tumors.

INSY was previously granted this designation for their treatment of glioblastoma multiforme (GBM) and two rare forms of epilepsy, Lennox-Gastaut Syndrome and Dravet Syndrome.
Orphan drug designation is granted to drugs that treat rare diseases that affect less than 200,000 patients in the U.S. The designation provides the drug developer with a seven-year period of U.S. marketing exclusivity, as well as certain financial incentives that can help support its development.

INSY has 7+ years of research and development experience in the pharmaceutical cannabinoid space. They manufacture pharmaceutical CBD and pharmaceutical dronabinol (THC) at their FDA-inspected and DEA approved facility in Round Rock, Texas. INSY submitted a Drug Master File (DMF #28255) for its CBD active pharmaceutical ingredient. The company believes that they are the only U.S.-based company with the capacity to produce pharmaceutical cannabinoids in scalable quantities.

INSY is up over 50% since early August and think they have a legs left to its run due to their extensive pipeline of drugs, as well as them trading on the NASDAQ exchange. The stock has been on a nice run recently and positive results from FDA testing should help push the stock to the low to mid 40s.

0 1983

Are You Keeping with The Times?

New marijuana users are trying the drug for the first time and as more states like New York see the health benefits of a smokeless delivery method versus a traditional smoking method, businesses and corporations are beginning to perfect methods that do not involve directly inhaling a smoldering plant. For starters, the market for marijuana edibles is exploding, particularly in those states that have legalized cannabis for medical/recreational use.  In Colorado for example, Cannabis purchases by out-of-state visitors account for an estimated 44% of all retail sales in the Denver area and about 90% in mountain resorts, according to a recent market study commissioned by the Colorado Marijuana Enforcement Division.

Colorado’s largest maker of infused products, Dixie Elixirs, recently moved to a new industrial building in Montbello with four times as much space as its former facility in Stapleton. Another major firm, Medically Correct, is moving from a 1,200sqft kitchen in the Platte Valley to a nearby building with 8,000 square feet. This also includes production facilities for its “Incredibles-branded” chocolate bars as well as space, to grow its own marijuana.

“We’re bursting at the seams,” said Medically Correct co-owner Bob Eschino. “Now we think we’ve already outgrown this (new space) before we’ve even started. There are other products we want to do but can’t come out with because we can’t even keep up with demand for chocolate.”

As edibles allow marijuana users to “ease into the drug”, the vaporizer and e-liquids space has just started to emerge for smokers to achieve a “cleaner high” and a more healthy alternative compared to that of rolling a joint. There are a lot more options available with customization, different e-liquids, and products that can heat both dry herb, liquid, and wax.  Just as e-cigarettes have dramatically changed the business of tobacco smoking, e-cig technology and vaping are bringing excellerated change to cannabis markets.

Steve DeAngelo, a marijuana entrepreneur and activist who founded the Harborside Health Center medical marijuana dispensary in Oakland, told USA Today that “The arrival of compact, portable, microprocessor-controlled vaporizers and advances in extracting active ingredients from cannabis plants have caused a shift in consumer demand.”

Some dispensaries such as his and many in Colorado, where recreational pot is legal, now do roughly 50% of their business in raw marijuana leaf or flowers, and the rest in edibles and concentrates, some prepackaged in cartridges for use in vape pens.

“The percentage of raw (pot) flowers we sell has been dropping steadily,” DeAngelo said. “The percent of extracts and concentrates … has been rising steadily.”

The arrival of marijuana vaporizing goes hand in hand with the recent development of highly concentrated forms of marijuana extractions in liquid both viscous and waxy forms. Those concentrates are easily consumed through vaporization and are used to fuel many of the vape pens on the market.

0 4871

Study: Couples who smoke marijuana are less likely to engage in domestic violence.

A new study by researchers at the University of Buffalo finds a significantly lower incidence of domestic violence among married couples who smoke pot. “Couples in which both spouses used marijuana frequently reported the least frequent IPV [intimate partner violence] perpetration,” the study concludes.

These findings were robust even after controlling for things like demographic variables, behavioral problems, and alcohol use. The authors studied data from 634 couples over nine years of marriage, starting in 1996. Couples were administered regular questionnaires on a variety of issues, including recent drug and alcohol use and instances of physical aggression toward their spouses.

Previous research on the relationship between marijuana use and domestic violence has largely been based on cross-sectional data (that is, data from one point in time), and those findings have been mixed: some studies found links between marijuana use and/or abuse and domestic violence, while others did not. The Buffalo study is one of the few to use data collected over the course of decades to examine the question, putting it on solid methodological ground compared to previous work.

The authors caution that while these findings are predictive–meaning couples who smoke are less likely to commit domestic violence–they don’t necessarily draw a causal line between the two behaviors. Among the connections they hypothesize, “marijuana may increase positive affect, which in turn could reduce the likelihood of conflict and aggression.” Translation: stoned people are happy, and happy people don’t fight.

Another possible mechanism: “chronic [marijuana] users exhibit blunted emotional reaction to threat stimuli, which may also decrease the likelihood of aggressive behavior.”

Since some of the data used in the study is now nearly two decades old, the authors would like to see if these findings would hold true among current newlyweds, particularly in light of “the trend toward marijuana decriminalization in the United States and potentially more positive attitudes toward its use.”

The authors said that more research also needs to be done on other dimensions of marijuana use, including abuse, dependence, and withdrawal, all behavioral states that may have different effects on how spouses interact with each other.

Nonetheless the paper is a solid contribution to the marijuana literature, and we’ll need a lot more like it as the country seems to move toward overall legalization. In fact, the DEA significantly bumped up the federal government’s marijuana production quota this year, in order to provide the raw material for more research on marijuana use.

We’re also learning a lot from Colorado’s legalization experiment, and a Brookings Institution paper out this week (Washington’s Marijuana Legalization Grows Knowledge, Not Just Pot) finds that the state is “devoting resources to tracking its experiment in an unusually meticulous way, with lessons that extend well beyond drug policy.”

Perhaps most significantly, the Buffalo study was funded partially by a grant from the National Institute for Drug Abuse. Marijuana reformers have strongly criticized NIDA’s institutional biases against marijuana legalization in the past, including restrictions the agency has placed on the availability of marijuana for research purposes. But the fact that NIDA is funding studies like this one suggests that it, like much of the country, is beginning to change its tune.

0 1561

Affinor Growers expects to complete the acquisition of RoofTop.

Affinor Growers (RSSFF: OTCQB) announced that they expect to complete the previously announced acquisition of all the issued and outstanding securities of RoofTop. This agreement was first announced on September 11, 2014. RoofTop will receive a cash payment of $500,000 and 1,636,363 shares of common stock of RSSFF as soon as the City of Vancouver executes the lease assignment. There was a delay that occurred and was unexpected, which caused the parties to amend the agreement, extending the closing date until October 3, 2014.

The Intellectual Property that Affinor will receive from this acquisition is very important to the company and will be useful in the future development and production aspects in the United States.

Shares of RSSFF responded very favorably to this announcement and shares were up 15% today. RSSFF is up over 25% since September 24th and we see legs left to this run. Shares are trading below their 20 and 50 day moving average, but positive news and high volume will help the stock breakout to the upside.

0 1703

Mike Adams from HighTimes.com Thank You!

While Alaska and Oregon are the next two states gearing up to vote on whether or not to establish a recreational marijuana market, cannabis supporters have already started working on campaigns for 2016. The Marijuana Policy Project announced last week that it had filed the necessary paperwork to get started with initiatives in both Arizona and California, which are aimed at establishing retail pot markets similar to what has been done in Colorado and Washington. In addition, the group also plans to expand its efforts in the near future to the states of Delaware, Hawaii, Maryland, Maine, Massachusetts, Nevada, New Hampshire, Rhode Island and Vermont.

Here is what your pot-friendly legislators were up to last week:

Arizona: 2016 Initiative Underway

Marijuana supporters in Arizona are set to begin their campaign to legalize the leaf in 2016. The Marijuana Policy Project initiative seeks to allow adults 21 and over to possess and use up to an ounce of weed. The initiative will essentially establish a cannabis market similar to what is currently going on in Colorado.

And while the campaign is expected to feel some resistance from law enforcement agencies, supporters believe there will be enough support from the voters to see this effort to fruition.

New Jersey: PTSD Added to Medical Marijuana Program?

A bill was introduced last week in the New Jersey legislature that would add Post Traumatic Stress Disorder to the medical marijuana program’s list of qualified conditions. Assembly Bill 3726, which is sponsored by Vincent Mazzeo and Linda Stender, would allow patients suffering from PTSD to finally receive the medicine they need to combat this severe anxiety condition.

“[We] have long hoped that PTSD would be the first condition that would be added to qualify for marijuana therapy in New Jersey,” Ken Wolski, Executive Director for the Coalition for Medical Marijuana New Jersey, said in a statement. “PTSD is poorly managed by traditional pharmacologic intervention–22 veterans commit suicide every day here in the U.S.”

Assembly Bill 3726 is set to go before the Assembly Health and Senior Services Committee for consideration.

Illinois: Medical Marijuana Application Deadline

The deadline for submitting an application for a medical marijuana business in Illinois has come to a close. The Department of Financial and Professional Regulation along with the Department of Agriculture accepted applications for dispensaries and cultivation centers until 3pm last Monday.

Although the state’s medical marijuana law went into effect at the beginning of the year, no cultivation has been allowed until after the state issues the first round of permits towards the end of the year. Illinois is expected to issue 21 cultivation permits and around 60 for dispensaries.

However, only those serious about working in the industry were able to apply — the state charged a non-refundable application fee of $25,000. Reports indicate the state collected in upwards of $5 million is non-refundable fees.

California: Legalization Efforts Start for 2016

The Marijuana Policy Project announced last week that it had officially launched its campaign to legalize recreational marijuana in California. That means the group can now begin accepting campaign contributions and collecting the signatures needed to get their initiative on the 2016 ballot.

“A diverse coalition of activists, organizations, businesses and community leaders will be joining together in coming months to draft the most effective and viable proposal possible,” Marijuana Policy Project Executive Director Rob Kampia said in a press release. “Public opinion has been evolving nationwide when it comes to marijuana policy, and Californians have always been ahead of the curve.”

Ohio: Medical Marijuana Likely in Ohio

Attorney General Mike DeWine recently announced that he would support legislation to legalize medical marijuana in Ohio, but has some concerns about how it will be drafted. “I think we have to be very careful, I would want to see that constraints are put in place to do that,” DeWine told 10TV. “Ultimately, it’s going to come to a vote for the voters of the state of Ohio. We will follow whatever law that the voters approve.”

Marijuana supporters attempted to get a ballot initiative approved for this year’s November election, but failed to gather to required signatures. However, the group said over the summer that they would try again in 2015 with more financial support behind them.

Connecticut: Medical Marijuana Sales Set to Begin

Medical marijuana patients in Connecticut will soon have access to cannabis. It was reported last week that the state’s first pot crop was set for distribution. “We are on track to make a Monday delivery,” Daniel Emmans, chief operating officer at Theraplant LLC told CT Now. “Over the weekend, we will be arranging the deliveries at the dispensaries.”

Initial prices for Connecticut’s medical marijuana program will range somewhere between $17 and $20 per gram.

Pennsylvania: Medical Marijuana Approved

The Pennsylvania state senate has voted in support of legislation to legalize medical marijuana. Last week, in a vote of 43-7, the Senate approved a measure introduced earlier this year by senator Daylin Leach. However, there is a distinct possibility the bill will not have an opportunity to pass during the current legislative session, which could mean it might have to wait to be reintroduced next year.

Initially, there was some fear that the proposal would be reduced to a CBD-only bill, but it has survived the process and remained intact. “This is not a CBD only bill,” said Senator Mike Folmer, who co-sponsored the legislation. “The list of diseases can be expanded. This is a work in progress to help as many as we can. The concerns with the original bill kept us from moving forward and getting any vote.”

source: http://www.hightimes.com/read/high-times-legislative-roundup-sept-29?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+HIGHTIMESMagazine+%28HIGH+TIMES+Magazine%29

0 1816

Get Your Resumes Ready

The quickly developing marijuana industry is generating an extraordinary and historic amount of available marijuana-related jobs throughout the United States and Canada, according to job listing website 420careers.com.

“The marijuana industry is producing more new jobs than many other industries in the United States. Each state that passes a medical or recreational marijuana law usually generates hundreds, if not thousands, of new jobs,” said Colby Ayres, the Director of Marketing at 420careers.com, in a press release issued Monday.

“Colorado currently has over 10,000 jobs associated with the marijuana industry and Washington state is quickly creating hordes of new jobs since legalizing marijuana in July,” Ayres added.

It has been predicted that over a dozen more states are likely to legalize recreational marijuana for adult use by 2018, which would potentially grow upwards of a $10 billion industry in the United States.

420careers.com provides a free place for marijuana-related businesses to post available marijuana jobs and browse job-seekers’ resumes; while, job-seekers can freely browse and apply for marijuana jobs, as well as post their resumes.

source: http://www.thedailychronic.net/2014/37174/retail-medical-marijuana-industry-job-openings-at-historic-high/

0 2003

Marijuana Edibles Industry Overview

The explosion of marijuana edibles to consume both medical and recreational marijuana created a brand new market offering a variety of baked goods, candies, desserts, cold beverages and frozen foods. The popular magazine “High Times” even has a unique cook book called “Official High Times Cannabis Cookbook”. This industry is poised to see significant growth as more and more states shift towards legalization.

There is plenty of money to be made which has been proven in legalized states like Colorado and Washington where many pot users turned to edibles because they don’t like to smoke or inhale marijuana any longer. Scientists proved the “high” effect lasts longer and can be stronger if its consumed opposed to inhaling it. Patients who are prescribed medical marijuana have also shifted to edibles for that reason alone.

The Keys to Success: Quality Testing and Regulations

Earlier this year a college student took his own life after consuming “too many” marijuana edibles. There are several other stories that raise concerns, however with any product in a brand new industry that alters your mindset such as alcohol and marijuana, regulations and guidelines are vital to its success.

Colorado’s Marijuana Enforcement Division (MED) provided a new set of rules in September 2014. The new proposed rules, almost 30 of them, are related to every aspect of the edible industry. Here are a few of those aspects:

  • Start-up licensing fees
  • Production caps on greenhouses or outdoor growing
  • Responsible Vendor Training
  • Product Testing
  • Hand-washing requirement
  • Single serving size does not have more than 10 milligrams of active THC

Colorado issued over 18,000 marijuana occupational licenses. With the new rules in effect, any individual that holds a license must comply with the new training standards at any shop, cultivation center, testing facility or manufacturer. Currently there a little less than 500 licensed medical marijuana shops and close to 250 recreational marijuana stores.

Washington, which just legalized recreational marijuana as July 8th, hasn’t caught up to Colorado’s stricter regulations yet. The Washington state Liquor Control Board enforces rules that require recreational marijuana products to be labeled clearly, an easy to read and understand serving size and the product must be approved by the board before selling.

Addressing Concerns

The end goal is not to create any extra burden on business owners; however it is to ensure safe consumption of edible marijuana. Many business owners aren’t thrilled about the additional expense associated with more regulations, but the overall consensus is that this will be great for sales in the edible industry.

Marijuana testing facilities can only test products from licensed growers and cultivators. This raises a major issue for caregivers and home growers. MED has not yet determined whether they would permit caregivers access to testing services.

Another concern besides increased costs includes but not limited to is the possibility of competition from black markets causing an increase in prices.

 

Marijuana Edible Companies

  • Latteno Food Corporation (LATF: OTC Pink Sheets) is a very risky and speculative company and we do not recommend them. However they offer an extensive variety of edible products and are located in California.
  • Dixie Elixirs, LLC is a private company which is affiliated with Marijuana, Inc. (MJNA: OTCBB). They manufacture and distribute medical marijuana products such as THC-infused beverages, cannabis sub-lingual and cannabis capsules.

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
Ad Placements